Brain

Platform that connects older adults, caregivers and families wins national competition

MONTREAL, Oct. 29, 2025 /CNW/ - Canadian startup Root & Seed has won the 2025 AGE-WELL National Impact Challenge: Implementing…

2 months ago

Apollo Biowellness, Inc., Corporate Status and Merger Update

North Bergen, New Jersey--(Newsfile Corp. - October 29, 2025) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), is pleased to…

2 months ago

Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin

HOUSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company…

2 months ago

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025

SEATTLE and VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty…

2 months ago

Strategic Shift: Patient Experience Now Healthcare’s Top C-Suite Priority

New Report reveals that 101 hospital and health system leaders prioritize digital health and virtual care  to improve access and…

2 months ago

Luminopia Collaborates with Crunchyroll to Continue Building Its Extensive Content Library for Pediatric Lazy Eye Patients

Kids using Luminopia can now watch popular anime shows, further diversifying their content selection   CAMBRIDGE, Mass., Oct. 28, 2025…

2 months ago

Liberty Advisor Group Employees Volunteer with Shirley Ryan AbilityLab

CHICAGO, Oct. 28, 2025 /PRNewswire/ -- Employees from Liberty Advisor Group (Liberty), a premier management consulting firm that helps clients tackle…

2 months ago

BrainCo Bionic Hand Inspires a Child’s Journey Forward

BOSTON, Oct. 28, 2025 /PRNewswire/ -- In early September, a young boy named Ma received a brand-new hand — a…

2 months ago

SparingVision Doses First Patient with SPVN20 for Advanced Retinitis Pigmentosa in NYRVANA Trial

                 SparingVision Doses First Patient with SPVN20 for Advanced Retinitis Pigmentosa in NYRVANA Trial SPVN20 aims to restore visual acuity…

2 months ago

BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025

BURLINGTON, Mass. and JERUSALEM, Oct. 28, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),…

2 months ago